Catalyst Wire Dossier Catalyst Wire Dossier

TF2

BI-1060469 · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TF2, covering 2015-09-24 to 2016-08-31. Get the full timeline:

Most recent: Clinical Trial Update: TF2- Small Cell Lung Cancer Radio Immunotherapy [Phase 1, Phase 2]

See pricing